seed
Stage
2020
Founded
2
Investors
About
StemBond Technologies is a biotechnology company developing innovative stem cell technologies and proprietary biomaterials for regenerative medicine. They focus on solutions for tissue repair and regeneration in areas such as orthopaedics, cardiovascular diseases, and neurodegenerative disorders.
Explore StemBond Technologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.